Dublin, March 20, 2026 (GLOBE NEWSWIRE)-- The "ELISpot & FluoroSpot Assay Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering. The ...

Though HTS and Automation Have Lowered Revenue Potential, Market Is Still Thriving The diversity of biomolecules present in human cells and the need to characterize their presence in normal ...

Engagement of intracellular targets is often critical to drug mechanisms. Establishing a target engagement (TE) profile is an important step in small- molecule drug discovery as well as chemical probe ...

Scientists need cellular assay technologies that examine multiple parameters at the same time, optimize high throughput workflows, control atmospheric conditions, and reduce experimental variability.

Biochemical assays isolate a defined molecular interaction, while cell-based screening assays capture integrated cellular responses. Each format offers unique advantages and limitations within HTS ...

MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for ...

From protein translation to mitosis, fundamental cellular processes are multifaceted and dynamic. Researchers seeking to understand the inner workings of a cell benefit from multidisciplinary ...

Cell-based assays are used to study genes, proteins, and whole cellular functions, as well as the mechanisms that control them, by measuring specific cellular parameters. They have become an important ...

The disposition of antibody-based therapeutics is generally determined by both target-mediated and non-target processes, the latter being an often-overlooked aspect. Target-independent liabilities can ...

Evaluation of interferon-alfa 2b in a model of acute respiratory distress syndrome and pulmonary fibrosis induced by intratraqueal bleomycin in Wistar rats This is an ASCO Meeting Abstract from the ...

TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery Promega Corporation is launching a new live-cell target engagement platform that could close a ...